From theheart.org on Medscape

Coverage from the

European Heart Rhythm Association (EHRA) 2020

Conference News

Popular News from EHRA 2019

  • ELIMINATE-AF: Edoxaban Viable Alternative to VKA in AF Ablation ELIMINATE-AF: Edoxaban Viable Alternative to VKA in AF Ablation Oral anticoagulant edoxaban was as efficacious and safe as a VKA for use in catheter ablation of atrial fibrillation, an exploratory trial shows. The major composite outcome and bleeding were similar.
  • Apple Heart Study Raises Myriad Questions Apple Heart Study Raises Myriad Questions The Apple Heart Study produced an 84% positive predictive value for atrial fibrillation, but it raises important questions about wearable consumer health devices and how medicine will deal with them.
  • Catheter for AF Maps, Ablates, and Sees Inside the Heart Catheter for AF Maps, Ablates, and Sees Inside the Heart A balloon catheter in development to treat atrial fibrillation incorporates ablation, mapping, and visualization inside the heart. An early study shows excellent rates of ablation and procedure time.

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.